PT  - JOURNAL ARTICLE
AU  - Evelyn Patricia Sánchez Espinoza
AU  - Marina Cortes Farrel
AU  - Saidy Vasconez Nogueira
AU  - Anderson Vicente de Paula
AU  - Thais Guimarães
AU  - Lucy Santos Villas Boas
AU  - Marcelo Park
AU  - Cristina Carvalho da Silva
AU  - Ingra Morales
AU  - Lauro Vieira Perdigão Neto
AU  - Tania Regina Tozetto-Mendoza
AU  - Icaro Boszczowski
AU  - Ester Sabino
AU  - Maria Cássia Mendes-Correa
AU  - Anna Sara Shafferman Levin
AU  - Silvia Figueiredo Costa
TI  - Are Mobile Phones part of the chain of transmission of SARS-CoV-2 in the hospital?
AID  - 10.1101/2020.11.02.20224519
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.02.20224519
4099  - http://medrxiv.org/content/early/2020/11/04/2020.11.02.20224519.short
4100  - http://medrxiv.org/content/early/2020/11/04/2020.11.02.20224519.full
AB  - SARS-CoV-2 cross-transmission has become an concern in hospitals. We investigate healthcare workers(HCWs) knowledge about SARS-CoV-2 cross-transmission and conceptions whether the virus can remain on HCWs mobile phones(MPs) and be part of the chain of transmission.A cross-sectional study was conducted at a COVID-19 Intensive Care Unit of a teaching-hospital. Fifty-one MPs were swabbed and a questionnaire about hand hygiene and MP use and disinfection was applied after an educational campaign. Although most of HCWs believed on the importance of cross-transmission and increased hand hygiene adhesion and MP disinfection during the pandemic, SARS-CoV-2 RNA was detected in two MPs(culture of the samples was negative).Implementation of official hospital policies to guide HCWs regarding disinfection and care of personal MP are needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by using materials from LIM-49 Bacteriology Laboratory from the Universidade de Sao Paulo. No grants were used for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Plataforma Brasil and CAPPESQ ethics committee approval number: 4.153.521All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data or references to data supporting the findings of this study are available within the article, further information may be requested to the corresponding author.